Stifel raises Ligand Pharmaceuticals target price to $350 from $332
LGND•Stifel raised its target price for Ligand Pharmaceuticals to $350 from $332.
Related News
Tyler Technologies target price raised to $430 from $400
TYL•
Nayax files initial beneficial ownership statement for CCO Moshe Orenstein
NYAX•
Canada's Imperial Oil Q3 revenue misses expectations on higher commodity prices
IMO•
Intensity Therapeutics schedules third-quarter financial results release
INTS•
Real Remax Group survey says higher mortgage rates weigh on housing demand and 2027 outlook
REAX•